Back to results
US 2024/0201190 A1Published application
Compositions and methods of diagnosing pancreatic cancer
AssigneeThe Regents of the University of California
InventorsSam L. IVRY, Anthony J. O'DONOGHUE, Kimberly KIRKWOOD, Charles S. CRAIK
Life of this patent
Estimating the term…
Abstract
The present disclosure relates generally to detection of molecular biomarkers in a sample or diagnosis of a subject based upon detection or quantification of molecular biomarkers in a sample, specifically to the identification and use of biomarkers for pancreatic cysts.
Claims16
1-59. (canceled)
A method of determining whether a subject has a mucinous cyst or malignant growth comprising detecting the presence, absence, or quantity of CEA in a sample of the subject, wherein the sensitivity to detecting CEA is equal to or greater than 70%.
-75. (canceled)
Dependencies are inferred from the claim text.